Dr. Daniel Reuven Gold, MD
- Medicare services, 2024
- 2,677
- Medicare patients, 2024
- 731
- Part D claims, 2024
- 1,904
- MIPS score, 2024
- 94
- Hospital affiliations
- 1
- Practice address
- 222 Bloomingdale Rd, White Plains, NY 10605
- Practice phone
- Call (914) 333-5800
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
ENT and Allergy Associates
White Plains, New York
Find Dr. Gold's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Daniel Reuven Gold is an otolaryngologist in White Plains, New York
Dr. Gold practices at ENT and Allergy Associates in White Plains, New York.
Dr. Gold's NPI, 1902927312, was assigned on April 3, 2007. Dr. Gold graduated from State University of New York Downstate Medical Center in 2002. Dr. Gold holds New York license 244098.
- NPI
- 1902927312NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3779671623
- NPI enumeration date
- April 3, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (914) 333-5800
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 50
- Medical school graduation
- 2002
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Daniel Reuven Gold practices at ENT and Allergy Associates in White Plains, New York
Dr. Gold's primary practice is ENT and Allergy Associates, at 222 Bloomingdale Rd, White Plains, NY 10605 in Westchester County. The practice phone is (914) 333-5800.
- ENT and Allergy Associates222 Bloomingdale Rd, White Plains, NY 10605 · Westchester CountyPhone(914) 333-5800
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Daniel Reuven Gold is affiliated with 3 sites of care and 1 medical group
Dr. Gold's primary practice is ENT and Allergy Associates in White Plains, New York. Dr. Gold is also affiliated with White Plains Hospital. The medical group on file is ENT and Allergy Associates. Dmand AI also links Dr. Gold to 1 more group practice or clinic, named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Daniel Reuven Gold's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gold practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| ENT and Allergy Associates | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Daniel Reuven Gold is one of 660 otolaryngologists in New York
Otolaryngology is Dr. Gold's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Gold is licensed in New York.
Specialties and state licenses
- Otolaryngology, New YorkPrimary
Otolaryngologists near Dr. Gold
Counts of otolaryngologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Daniel Reuven Gold billed Medicare for 2,677 services in 2024
CMS data shows 2,677 Medicare services from Dr. Gold across 16 procedure codes in 2024, for 731 Medicare patients. Medicare paid $267,352 for them. Every service was in an office.
Dr. Gold's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Surgery
- 2023: 9832024: 1,16719%
- Office and hospital visits
- 2023: 9802024: 1,12415%
- Tests and treatments
- 2023: 2272024: 2301%
- Other services
- 2023: 732024: 775%
- Drugs given in the office
- 2023: 312024: 64106%
- Imaging
- 2023: 152024: 15No change
Dr. Gold compared with the New York median for otolaryngologists, 2024
- Dr. Gold
- New York median
- Medicare services
- 2,677vs 7203.7 times
- Medicare patients
- 731vs 2962.5 times
- Part D claims
- 1,719vs 2985.8 times
Medians across 638 otolaryngologists in New York with Dmand AI profiles that report each measure.
Dr. Gold's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Gold?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Gold and other otolaryngologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Daniel Reuven Gold treated 731 Medicare patients in 2024, average age 75
CMS counts 731 Medicare patients who saw Dr. Gold in 2024. The largest group is 65 to 74, with 306 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Gold's median patient age at 59, with 53% women.
Dr. Gold's Medicare patients by age, 2024
Dr. Gold's Medicare patients by sex, 2024
- Women43760%
- Men29440%
Chronic conditions among Dr. Gold's Medicare patients, 2024
- High cholesterol75%
- High blood pressure62%
- Arthritis47%
- Ischemic heart disease25%
- Osteoporosis24%
- Anxiety23%
- Cancer21%
- Diabetes21%
Share of Medicare patients with each condition. A patient can have several.
Dr. Gold's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 59
Patient panel by sex, all payers
- Women53%
- Men41%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Daniel Reuven Gold wrote 1,904 Medicare Part D claims in 2024
In 2024, Dr. Gold wrote 1,904 Medicare Part D claims for 590 patients. 94% of them were for generic drugs. CMS names the drug for 1,719 of them, across 32 drugs with 11 or more claims each, at $135,546 in total drug cost. In 2023, CMS named 1,271 claims across 27 drugs.
Dr. Gold's Part D claims by kind of drug, 2024
- Generic1,797 claims94%
- Brand-name107 claims6%
Dr. Gold's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Gold's Part D claims, 2024
- Antibiotics12%226 of 1,904 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,2712024: 1,71935%
Drugs named by CMS: 32 in 2024, 27 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Daniel Reuven Gold scored 94 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Gold for performance year 2024, reported as part of a group. Dr. Gold accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Gold's MIPS scores, performance year 2024
- 94of 100Final score
- 89.9of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)
Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Daniel Reuven Gold received $4,486 in industry payments from 2016 to 2025
CMS Open Payments shows 163 general payments to Dr. Gold from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Optinose US, Inc. paid the most, $833.
General payments to Dr. Gold by program year, 2016 to 2025
General payments to Dr. Gold by kind, 2016 to 2025
- Food and beverage$3,90787%
- Honoraria$4009%
- Travel and lodging$1223%
- Education$571%
Companies that paid Dr. Gold the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Daniel Reuven Gold graduated from State University of New York Downstate Medical Center
Dr. Gold graduated from State University of New York Downstate Medical Center in 2002.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Daniel Reuven Gold's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Daniel Reuven Gold
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Daniel Reuven Gold's NPI number?
Dr. Daniel Reuven Gold's NPI number is 1902927312. It was assigned on April 3, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Daniel Reuven Gold?
Dr. Daniel Reuven Gold is an otolaryngologist in White Plains, New York. The primary specialty in the NPI Registry is Otolaryngology Physician (taxonomy code 207Y00000X).
Where does Dr. Daniel Reuven Gold practice?
Dr. Gold practices at 222 Bloomingdale Rd, White Plains, NY 10605. Dr. Gold's primary practice is ENT and Allergy Associates in White Plains, New York. Dmand AI also links Dr. Gold to 1 group practice or clinic.
What is Dr. Daniel Reuven Gold's office phone number?
The practice phone on file for Dr. Gold is (914) 333-5800.
What is Dr. Daniel Reuven Gold's medical license number?
Dr. Gold holds New York license 244098.
Which hospitals is Dr. Daniel Reuven Gold affiliated with?
Dr. Gold is affiliated with White Plains Hospital.
What medical group is Dr. Daniel Reuven Gold part of?
Dr. Gold is linked to ENT and Allergy Associates.
Does Dr. Daniel Reuven Gold accept Medicare?
Yes. CMS data shows Dr. Gold billed Medicare for 2,677 services in 2024, and Dr. Gold accepts Medicare assignment.
What is Dr. Daniel Reuven Gold's MIPS score?
Dr. Gold's MIPS final score for performance year 2024 is 94 out of 100, reported as part of a group.
How many Medicare patients does Dr. Daniel Reuven Gold see?
CMS counts 731 Medicare patients who saw Dr. Gold in 2024, with an average age of 75.
Show 5 more questionsShow fewer questions
What services does Dr. Daniel Reuven Gold bill to Medicare?
In 2024, Dr. Gold's most billed Medicare services were surgery: lungs and airway (31231), office visit, established patient (99214) and surgery: ear (69210).
Where did Dr. Daniel Reuven Gold go to medical school?
Dr. Gold graduated from State University of New York Downstate Medical Center in 2002.
What drugs does Dr. Daniel Reuven Gold prescribe most?
In 2024 Medicare Part D data, Dr. Gold's most prescribed drugs by claims were Ipratropium Bromide, Azelastine HCl and Fluticasone Propionate.
Has Dr. Daniel Reuven Gold received payments from drug or device companies?
CMS Open Payments shows $4,486 in general payments to Dr. Gold from 31 companies from 2016 to 2025. The largest total came from Optinose US, Inc.
How long has Dr. Daniel Reuven Gold been practicing?
Dr. Gold graduated from medical school in 2002, 24 years ago.
Selling to otolaryngology practices?
See otolaryngologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card